Pharmacokinetic and clinical pharmacological studies with mepivacaine and prilocaine.
The tolerance and pharmacokinetic properties of mepivacaine and prilocaine were compared following i.v. infusion of 250 mg (0.88 and 0.97 mmol respectively) of each drug in five healthy volunteers. Side-effects were minor and occurred in only two subjects during the infusion of mepivacaine. Plasma concentrations of mepivacaine were greater in each subject than the corresponding values for prilocaine. The elimination half-life of mepivacaine was generally longer than that for prilocaine, whereas the total body clearance of prilocaine was consistently greater than the corresponding value for mepivacaine. For each subject the clearance of prilocaine substantially exceeded normal heptic blood flow and therefore an extra-hepatic site of metabolism of prilocaine has been postulated.
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004361:Drug Tolerance; D006801:Humans; D007263:Infusions, Parenteral; D007700:Kinetics; D008297:Male; D008619:Mepivacaine / Q000378:metabolism* / Q000494:pharmacology; D011318:Prilocaine / Q000378:metabolism* / Q000494:pharmacology; D011897:Random Allocation
D011318:Prilocaine; D008619:Mepivacaine